Company Filing History:
Years Active: 2024
Title: Yi-Shan Chen: Innovator in Gene Editing
Introduction
Yi-Shan Chen is a prominent inventor based in South Boston, MA (US). He has made significant contributions to the field of gene editing, particularly in relation to treating conditions associated with angiopoietin-like 3 (ANGPTL3). His innovative work has the potential to impact many lives.
Latest Patents
Yi-Shan Chen holds a patent for "Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions." This patent focuses on methods, compositions, and kits designed for treating conditions related to ANGPTL3 through gene editing. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Currently, Yi-Shan Chen is associated with Crispr Therapeutics AG, a leading company in the field of gene editing. His work at Crispr Therapeutics AG allows him to collaborate with other experts and contribute to groundbreaking advancements in genetic research.
Collaborations
Some of his notable coworkers include Sandeep Soni and Laura Serwer. Their collective efforts in the field of gene editing further enhance the innovative environment at Crispr Therapeutics AG.
Conclusion
Yi-Shan Chen is a key figure in the realm of gene editing, with a focus on treating ANGPTL3 related conditions. His contributions and collaborations are paving the way for future advancements in medical science.